FundingWatcher
Home / Startups / Top biotech startups / Biotech startups that raised Series B / Biotech startups that raised Series B in San Diego, California

Biotech startups that raised Series B in San Diego, California

Updated 16 Nov 2026

Reset
Biotech startups that raised Series B in San Diego, California
One-time CSV
  • 53 funded companies, 49 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-biotech--series-b~san-diego-california.csv53 rows × 18 columns
CompanyCityLast roundAmountDate
Mirador TherapeuticsSan DiegoSeries B$250.0M2026-01-12
BlossomHill TherapeuticsSan DiegoSeries B$84.0M2025-12-10
Avenzo TherapeuticsSan DiegoSeries B$60.0M2025-09-04
Actio BiosciencesSan DiegoSeries B$66.0M2025-06-18
Sirius TherapeuticsSan DiegoSeries B$50.0M2025-05-09
GallantSan DiegoSeries B$18.0M2025-03-15
Human LongevitySan DiegoSeries B$39.8M2024-08-21
Kate TherapeuticsSan DiegoSeries B$21.8M2024-08-07

8 rows of the CSV in 5 of its 18 columns.

53
Startups
$6.7B
Total raised
11
Funded in the last 12 months
$1.0B
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

10 of 53
10 rows
Company What they do Sector Last round Amount Date Total raised Investors Employees Founded
Mirador Therapeutics Mirador Therapeutics develops precision medicines for immune-mediated diseases. Biotech Series B $250.0M 2026-01-12 $730.0M OrbiMed, Fidelity, ARCH Venture Partners +1 11 to 50 2024
BlossomHill Therapeutics BlossomHill Therapeutics is a biopharmaceutical company focused on oncology and autoimmune disorders. Biotech Series B $84.0M 2025-12-10 $257.0M OrbiMed, Cormorant Asset Management, Vivo Capital +2 11 to 50 2020
Avenzo Therapeutics Avenzo Therapeutics develops oncology therapies for treating cancer. Biotech Series B $60.0M 2025-09-04 $841.9M New Enterprise Associates, Sands Capital Ventures, Lilly Asia Ventures +2 11 to 50 2022
Actio Biosciences Actio Biosciences develops drugs for rare diseases through its research center. Biotech Series B $66.0M 2025-06-18 $121.0M Canaan Partners, Euclidean Capital, Deerfield Management +2 11 to 50 2021
Sirius Therapeutics Sirius Therapeutics is a biotechnology company developing RNAi therapies for cardiovascular diseases. Biotech Series B $50.0M 2025-05-09 $110.0M OrbiMed, Hankang Capital, Creacion Ventures +1 11 to 50 2021
Gallant Gallant advances investigational stem cell therapies to extend the healthy years of pets. Biotech Series B $18.0M 2025-03-15 $44.0M Alumni Ventures, Bling Capital, Science +2 11 to 50 2018
Human Longevity Unicorn Human Longevity is a genomics-based health intelligence company supporting proactive healthcare. Biotech Series B $39.8M 2024-08-21 $369.8M StartUp Health, Amino Capital, Threshold +1 51 to 100 2013
Capstan Therapeutics Capstan Therapeutics develops in vivo mRNA and gene-editing medicines for a broad range of diseases. Biotech Series B $175.0M 2024-03-20 $340.0M RA Capital Management, OrbiMed, Alexandria Venture Investments +2 101 to 250 2021
MBrace Therapeutics MBrace Therapeutics is a privately held biopharmaceutical company. Biotech Series B $85.0M 2023-11-14 $110.0M Venrock, TPG, Alta Partners +2 11 to 50 2019
Tentarix Biotherapeutics Tentarix Biotherapeutics creates protein therapeutics with combined bioactivities using synthetic biology. Biotech Series B $35.0M 2023-09-06 $93.0M Versant Ventures, Samsara BioCapital, Amplitude Venture Capital 11 to 50 2020

Table 1. Biotech startups that raised Series B in San Diego, California: the 10 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 53.

Largest rounds

Last 12 months
# Company What they do Sector Last round Amount Date Total raised Investors Employees Founded
1 Mirador Therapeutics Mirador Therapeutics develops precision medicines for immune-mediated diseases. Biotech Series B $250.0M 2026-01-12 $730.0M OrbiMed, Fidelity, ARCH Venture Partners +1 11 to 50 2024
2 BlossomHill Therapeutics BlossomHill Therapeutics is a biopharmaceutical company focused on oncology and autoimmune disorders. Biotech Series B $84.0M 2025-12-10 $257.0M OrbiMed, Cormorant Asset Management, Vivo Capital +2 11 to 50 2020

Table 2. Biotech startups that raised Series B in San Diego, California: the 2 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 OrbiMed Private equity firm New York, United States 5 9% 2 Mirador Therapeutics, BlossomHill Therapeutics
2 Blue Owl Private equity firm New York, United States 2 4% 1 Mirador Therapeutics
3 Digitalis Ventures Venture capital firm New York, United States 2 4%
4 Bold Capital Partners Venture capital firm Santa Monica, United States 2 4%
5 Versant Ventures Venture capital firm Menlo Park, United States 2 4%
6 Alta Partners Venture capital firm Jackson, United States 2 4%
7 ARCH Venture Partners Venture capital firm Chicago, United States 1 2% 1 Mirador Therapeutics
8 Fidelity Investment bank Boston, United States 1 2% 1 Mirador Therapeutics
9 Cormorant Asset Management Hedge fund Boston, United States 1 2% 1 BlossomHill Therapeutics
10 Colt Ventures Family office Dallas, United States 1 2% 1 BlossomHill Therapeutics
11 Plaisance Capital Management Entrepreneurship program Natick, United States 1 2% 1 BlossomHill Therapeutics
12 Vivo Capital Private equity firm Palo Alto, United States 1 2% 1 BlossomHill Therapeutics
13 Lilly Asia Ventures Venture capital firm Shanghai, China 1 2%
14 Deep Track Capital Hedge fund Greenwich, United States 1 2%
15 INCE Capital Venture capital firm Pudong, China 1 2%

Table 3. Biotech startups that raised Series B in San Diego, California: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Health care 49 92% $6.6B
Software 2 4% $52.7M
Artificial intelligence 1 2% $52.7M

Table 4. Biotech startups that raised Series B in San Diego, California by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Series B 53 100% $45.0M

Table 5. Biotech startups that raised Series B in San Diego, California by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Rounds by month

Rounds by monthCompaniesShareRaised
October 2026 1 9% $80.0M
August 2026 2 18% $76.0M
July 2026 2 18% $130.0M
April 2026 2 18% $237.0M
January 2026 2 18% $273.3M
December 2025 2 18% $214.0M

Table 6. Biotech startups that raised Series B in San Diego, California: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2026 9 17% $796.3M
2025 7 13% $426.0M
2024 7 13% $600.6M
2023 4 8% $250.2M
2022 2 4% $52.0M
2021 5 9% $276.0M

Table 7. Biotech startups that raised Series B in San Diego, California by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2023 or later 5 9%
2020 to 2022 12 23%
2015 to 2019 14 26%
2010 to 2014 9 17%
Before 2010 13 25%

Table 8. Biotech startups that raised Series B in San Diego, California by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
1 to 10 8 15%
11 to 50 33 62%
51 to 100 7 13%
101 to 250 3 6%
1,001 to 5,000 1 2%
5,001 to 10,000 1 2%

Table 9. Biotech startups that raised Series B in San Diego, California by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many biotech startups in San Diego, California whose last round is Series B are on the list?
53, in the file dated 16 November 2026. 11 of them closed their most recent round in the last 12 months.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 53 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Biotech startups that raised Series B in San Diego, California: 53 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $199 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Biotech at other stages in San Diego

Other sectors that raised Series B in San Diego

Cite: FundingWatcher, 53 biotech companies in San Diego, California whose most recent round is Series B, 16 November 2026. https://fundingwatcher.com/startups/biotech/series-b/san-diego-california/